вЂњWe have a real chance to advance oxygen solutions for the long-term,вЂќ she says. Despite the challenges that come with pandemic response, Lisa says there are also opportunities. To respond to the pandemic, PATH and a coalition of partners are supporting countries in the development and execution of comprehensive respiratory care plans to respond to COVID-19. вЂњWeвЂ™re responding to the COVID-19 pandemic, improving global and national policies, and strengthening markets and implementation.вЂќ вЂњThatвЂ™s why we take a multifaceted approach,вЂќ says Lisa Smith, senior market dynamics officer at PATH and director of the COVID-19 Respiratory Care Response Coordination project. When it comes to medical oxygen and its associated tools (including pulse oximeters), scaling up access is a multifaceted challenge that cuts across health areas and requires technical, financial, and political solutions. вЂњWhat we need to do as a global community-and what PATH works to do every day,вЂќ Dykki says, вЂњis to accelerate the dissemination of new technology once advances have been made.вЂќ Wealthy countries are often the ones to advance technology because those customers can afford to pay top dollar, allowing companies to recoup the high costs of research and development. But, in the long run, these advances will benefit everyone.вЂќ He says that, вЂњLike all technological advances, high-cost wearables with pulse oximetry will briefly deepen the digital health divide. Dykki Settle is PATHвЂ™s chief digital officer and director of the Center of Digital and Data Excellence.

Pulse oximeter apple watch 2